Subscribe to our Newsletters !!

    Pharmacokinetics

    Researchers distinguish aggravates that square replication of COVID-19 infection

    Whilst the death toll from the COVID-19 pandemic mounts, the boffins worldwide carry on their push to create effective treatments and a vaccine to its highly infectious respiratory tract. The inhibitors demonstrate potent structural and chemical connections with an viral critical to this herpes virus’s capacity to proliferate. The very promising drug candidates – like

    Analysts recognize anticoagulation operator that stifles SARS-CoV-2 replication in vitro

    Effective antivirals with secure clinical profile are urgently needed to improve the overall prognosis. In an analysis of a randomly collected cohort of 124 patients using COVID-19, the authors discovered that hypercoagulability according to elevated levels of D-dimers was associated with illness severity. By calculating of a U.S. FDA approved drug library, the authors identified

    BioChromato’s RAPID Slit Seals offer significant advantages over customary silicone mats

    BioChromato Inc. reports that the pharmacokinetics department in a leading Japanese pharmaceutical company has found that RAPID Slit Seals provide significant benefits when compared with conventional silicone mats for maintaining the integrity of microplate samples. In their drive to identify new drug entities the pharmacokinetics division use a mass spectrometer served by an autosampler managing

    CN Bio presents the PhysioMimix™ OOC Multi-Organ Microphysiological System

    CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip (OOC), today announced the commercial launch of its new PhysioMimix™ OOC Multi-Organ MPS. The next-generation system unites CN Bio’s in vitro 3D liver model, whose phenotype and functions mimic that in vivo, with a range of other organs to